US 8017763
Chemically modified oligonucleotides
granted A61KA61K31/7088A61K31/713
Quick answer
US patent 8017763 (Chemically modified oligonucleotides) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/7088, A61K31/713, A61K47/54, A61K47/543